Colorectal cancer: Etiology, pathogenesis and current treatment
DOI:
https://doi.org/10.56511/JIPBS.2020.v7.i04.pp20-24Abstract
Colorectal cancer is define by partial suppression of apoptosis. This can give advantages to survival in tumours but cause the ineffective approach of chemotherapy treatment. New development in the research provide the novel approach of the new target therapy for the colorectal cancer treatment. The novel approach of the targeting therapies leads the new pathway treatment for the colorectal cancer and give the promising results. Progressive inhibition or evasion of apoptosis has been found during the transformation of colorectal epithelium to carcinoma, indicating that dysfunction of apoptosis has an important role in colorectal tumourigenesis. In this review the etiology, pathogenesis and current treatment is discussed.
Keywords:
Cancer, Colorectal cancer, Chemotherapy, Anatomy and physiologyDownloads
References
Bhatt P, Lalani R, Vhora I, Patil S, Amrutiya J, Misra A, et al. Liposomes encapsulating native and cyclodextrin enclosed paclitaxel: Enhanced loading efficiency and its pharmacokinetic evaluation. International Journal of Pharmaceutics 2018; 536(1):95-107.
Croce CM. Oncogenes and Cancer. New England Journal of Medicine. 2008; 358(5):502-11.
Patel J, Amrutiya J, Bhatt P, Javia A, Jain M, Misra A. Targeted delivery of monoclonal antibody conjugated docetaxel loaded PLGA nanoparticles into EGFR overexpressed lung tumour cells. J Microencapsul. 2018; 35(2):204-17.
Kaler P, Galea V, Augenlicht L, Klampfer L. Tumor associated macrophages protect colon cancer cells from TRAIL-induced apoptosis through IL-1beta-dependent stabilization of Snail in tumor cells. PloS one. 2010; 5(7):e11700.
Vatandoust S, Price TJ, Karapetis CS. Colorectal cancer: Metastases to a single organ. World journal of gastroenterology 2015; 21(41):1176776.
Burn J, Mathers J, Bishop DT. Genetics, inheritance and strategies for prevention in populations at high risk of colorectal cancer (CRC). Recent results in cancer research 2013; 191:157-83.
Chen MJ, Cheng YM, Lai PH, Wu JF, Hsu YC. In vitro biocompatibility of thermally gelling liquid mucoadhesive loaded curcuminoids in colorectal cancer chemoprevention. International journal of colorectal disease 2012; 27(7):869-78.
Niv Y, Goel A, Boland CR. JC virus and colorectal cancer: a possible trigger in the chromosomal instability pathways. Current opinion in gastroenterology 2005; 21(1):85-9.
Sancho E, Batlle E, Clevers H. Signaling pathways in intestinal development and cancer. Annual Review of Cell and Developmental Biology 2004; 20(1):695-723.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians 2018; 68(6):394-424.
Bhatt P, Vhora I, Patil S, Amrutiya J, Bhattacharya C, Misra A, et al. Role of antibodies in diagnosis and treatment of ovarian cancer: Basic approach and clinical status. J Control Release. 2016; 226:148-67.
Pinto D, Clevers H. Wnt, stem cells and cancer in the intestine. Biology of the cell. 2005; 97(3):185-96.
Ping Y, Ogushi Y, Okada Y, Haruki Y, Okazaki I, Ogawa T. Lifestyle and colorectal cancer: A case-control study. Environ Health Prev Med. 1998; 3(3):146-51.
Fearon ER. Molecular genetics of colorectal cancer. Annual review of pathology 2011; 6:479-507.
Strate LL, Syngal S. Hereditary colorectal cancer syndromes. Cancer causes & control : CCC. 2005; 16(3):201-13.
Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61(5):759-67.
Bhatt P, Khatri N, Kumar M, Baradia D, Misra A. Microbeads mediated oral plasmid DNA delivery using polymethacrylate vectors: an effectual groundwork for colorectal cancer. Drug Delivery 2015; 22(6):849-61.
Astin M, Griffin T, Neal RD, Rose P, Hamilton W. The diagnostic value of symptoms for colorectal cancer in primary care: a systematic review. The British journal of general practice: The journal of the Royal College of General Practitioners 2011; 61(586):e231-43.
Patil S, Bhatt P, Lalani R, Amrutiya J, Vhora I, Kolte A, et al. Low molecular weight chitosan – protamine conjugate for siRNA delivery with enhanced stability and transfection efficiency. RSC Advances. 2016; 6(112):110951-63.
Mishra J, Drummond J, Quazi SH, Karanki SS, Shaw JJ, Chen B, et al. Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis. Critical reviews in oncology/hematology 2013; 86(3):232-50.
Ilyas M, Straub J, Tomlinson IP, Bodmer WF. Genetic pathways in colorectal and other cancers. European journal of cancer (Oxford, England : 1990). 1999; 35(3):335-51.
Wolpin BM, Mayer RJ. Systemic treatment of colorectal cancer. Gastroenterology 2008; 134(5):1296-310.
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA: A cancer journal for clinicians. 2007; 57(1):4366.
Compton CC, Greene FL. The staging of colorectal cancer: 2004 and beyond. CA: A cancer journal for clinicians. 2004; 54(6):295-308.
Yewale C, Baradia D, Patil S, Bhatt P, Amrutiya J, Gandhi R, et al. Docetaxel loaded immunonanoparticles delivery in EGFR over expressed breast carcinoma cells. Journal of Drug Delivery Science and Technology 2018; 45:334-45.
Bhatt P, Lalani R, Mashru R, Misra A. Abstract 2065: Anti-FSHR antibody Fab’ fragment conjugated immunoliposomes loaded with cyclodextrin-paclitaxel complex for improved & efficacy on ovarian cancer cells. Cancer Research 2016; 76(14 Supplement):2065.
Vhora I, Patil S, Bhatt P, Gandhi R, Baradia D, Misra A. Receptortargeted drug delivery: current perspective and challenges. Ther Deliv. 2014; 5(9):1007-24.
Tandel H, Bhatt P, Keerti Jain, Aliasgar Shahiwala, Ambikanandan Misra. In-Vitro and In-Vivo Tools in Emerging Drug Delivery Scenario: Challenges and Updates. In: Misra ASA, editor. In-Vitro and In-Vivo Tools in Drug Delivery Research for Optimum Clinical Outcomes: CRC Press; 2018.
Patil S, Bhatt P, Lalani R, Amrutiya J, Vhora I, Kolte A, et al. Low molecular weight chitosan – protamine conjugate for siRNA delivery with enhanced stability and transfection efficiency. RSC Advances. 2016; 6(112):110951-63.
Published
How to Cite
Issue
Section
Copyright (c) 2020 Bhargavi Rathva, Shreyas V Desai
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at